Nalaganje...
Tocilizumab-Induced Acute Liver Injury in Adult Onset Still's Disease
Background. Tocilizumab, a monoclonal humanized anti-IL-6 receptor antibody, is used in treatment of refractory adult onset Still's disease (AOSD). Mild to moderate liver enzyme elevation is a well-known side effect, but severe liver injury has only been reported in 3 cases in the literature. C...
Shranjeno v:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Hindawi Publishing Corporation
2013
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4208420/ https://ncbi.nlm.nih.gov/pubmed/25374723 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/964828 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|